Jade Biosciences, Inc. Common Stock

JBIONASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
22.18 USD
↘ 0.06 (0.27%)🟢LIVE (AS OF 10:32 AM EDT)
🟢Market: OPEN

Jade Biosciences, Inc. Common Stock (JBIO) trades at $22.18 per share. Technical indicators currently signal "Strong Buy". This is driven by negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, JBIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$22.76
High?$23.17
Low?$21.07
Prev. Close?$22.24
Volume?84.8K
Avg. Volume?1.0M
VWAP?$22.46
Rel. Volume?0.08x
Bid / Ask
Bid?$19.20 × 100
Ask?$22.39 × 100
Spread?$3.19
Midpoint?$20.80
Valuation & Ratios
Market Cap?1.4B
Shares Out?49.4M
Float?41.4M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?4.57
EPS?-$1.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
55
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.jadebiosciences.com
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?18.20%High
Short Interest?7.5M
Days to Cover?7.2
Free Float41.4M
Avg Daily Volume1.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?14.29Strong
Quick Ratio?14.29Strong
Cash Ratio?2.47Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
40
4.57FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-38.8%WEAK▾
ROA?
S&P
3
-36.0%WEAK▾
Cash Flow & Enterprise
FCF?$-101690000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day
MarketsMoversWatchlist